134 related articles for article (PubMed ID: 14609210)
1. Control of T cell activation by CD4+CD25+ suppressor T cells.
Shevach EM; Piccirillo CA; Thornton AM; McHugh RS
Novartis Found Symp; 2003; 252():24-36; discussion 36-44, 106-14. PubMed ID: 14609210
[TBL] [Abstract][Full Text] [Related]
2. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells.
Suri-Payer E; Amar AZ; Thornton AM; Shevach EM
J Immunol; 1998 Feb; 160(3):1212-8. PubMed ID: 9570536
[TBL] [Abstract][Full Text] [Related]
3. Activation requirements for the induction of CD4+CD25+ T cell suppressor function.
Thornton AM; Piccirillo CA; Shevach EM
Eur J Immunol; 2004 Feb; 34(2):366-76. PubMed ID: 14768041
[TBL] [Abstract][Full Text] [Related]
4. Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells.
Fehérvári Z; Sakaguchi S
Int Immunol; 2004 Dec; 16(12):1769-80. PubMed ID: 15520045
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation.
Kullberg MC; Hay V; Cheever AW; Mamura M; Sher A; Letterio JJ; Shevach EM; Piccirillo CA
Eur J Immunol; 2005 Oct; 35(10):2886-95. PubMed ID: 16180248
[TBL] [Abstract][Full Text] [Related]
6. Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent.
Valzasina B; Piconese S; Guiducci C; Colombo MP
Cancer Res; 2006 Apr; 66(8):4488-95. PubMed ID: 16618776
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease.
Horwitz DA; Zheng SG; Gray JD; Wang JH; Ohtsuka K; Yamagiwa S
Semin Immunol; 2004 Apr; 16(2):135-43. PubMed ID: 15036237
[TBL] [Abstract][Full Text] [Related]
8. CD4+ CD25+ regulatory T cells control the magnitude of T-dependent humoral immune responses to exogenous antigens.
Eddahri F; Oldenhove G; Denanglaire S; Urbain J; Leo O; Andris F
Eur J Immunol; 2006 Apr; 36(4):855-63. PubMed ID: 16511897
[TBL] [Abstract][Full Text] [Related]
9. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
[TBL] [Abstract][Full Text] [Related]
10. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
[TBL] [Abstract][Full Text] [Related]
11. How do CD4+CD25+ regulatory T cells control autoimmunity?
Bluestone JA; Tang Q
Curr Opin Immunol; 2005 Dec; 17(6):638-42. PubMed ID: 16209918
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.
Gonzalez-Rey E; Fernandez-Martin A; Chorny A; Delgado M
Arthritis Rheum; 2006 Mar; 54(3):864-76. PubMed ID: 16508968
[TBL] [Abstract][Full Text] [Related]
14. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.
Keino H; Takeuchi M; Kezuka T; Hattori T; Usui M; Taguchi O; Streilein JW; Stein-Streilein J
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1047-55. PubMed ID: 16505040
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo activated OVA specific and non-specific CD4+CD25+ regulatory T cells exhibit comparable suppression to OVA mediated T cell responses.
Li J; Bracht M; Shang X; Radewonuk J; Emmell E; Griswold DE; Li L
Cell Immunol; 2006 Jun; 241(2):75-84. PubMed ID: 17010326
[TBL] [Abstract][Full Text] [Related]
16. Development and function of naturally occurring CD4+CD25+ regulatory T cells.
Toda A; Piccirillo CA
J Leukoc Biol; 2006 Sep; 80(3):458-70. PubMed ID: 16809644
[TBL] [Abstract][Full Text] [Related]
17. Interference with CD4+CD25+ T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody.
Morris GP; Kong YC
J Autoimmun; 2006 Feb; 26(1):24-31. PubMed ID: 16253477
[TBL] [Abstract][Full Text] [Related]
18. Gld mutation of Fas ligand increases the frequency and up-regulates cell survival genes in CD25+CD4+ TR cells.
Mohamood AS; Trujillo CJ; Zheng D; Jie C; Murillo FM; Schneck JP; Hamad AR
Int Immunol; 2006 Aug; 18(8):1265-77. PubMed ID: 16769751
[TBL] [Abstract][Full Text] [Related]
19. Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells.
Scotto L; Naiyer AJ; Galluzzo S; Rossi P; Manavalan JS; Kim-Schulze S; Fang J; Favera RD; Cortesini R; Suciu-Foca N
Hum Immunol; 2004 Nov; 65(11):1297-306. PubMed ID: 15556680
[TBL] [Abstract][Full Text] [Related]
20. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid.
van Amelsfort JM; Jacobs KM; Bijlsma JW; Lafeber FP; Taams LS
Arthritis Rheum; 2004 Sep; 50(9):2775-85. PubMed ID: 15457445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
